Back to results
US 5,648,335 AGranted
Prevention and treatment of peripheral neuropathy
AssigneesCephalon, Inc., Albert Einstein College of Medicine of Yeshiva Univ.
InventorsMichael E. Lewis, Stuart C. Apfel, John A. Kessler
Life of this patent
Estimating the term…
Abstract
The invention features a method of using insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to prevent or treat peripheral neuropathy in a mammal.
Claims3
A method of reducing a hereditary peripheral neuropathy that is not caused by an abnormal insulin level in a mammal, said method comprising
- administering a neuropathy-reducing amount of insulin-like growth factor-I (IGF-I) or insulin-like growth factor-III (IGF-III) to said mammal.
Dependencies are inferred from the claim text.